Medical Marijuana Takes A ‘Back Seat’ As Adult-Use Legalization Gains Momentum

As the cannabis industry evolves, the conversation surrounding medical marijuana appears to be shifting to the background. Once central to cannabis reform, medical marijuana now seems to receive less focus compared to adult-use legalization in policy discussions.

With new state and federal regulations on the horizon, this shift raises concerns about how medical marijuana fits into the broader cannabis landscape.

Debra Borchardt, the executive editor and co-founder of Green Market Report, shared her perspective on the diminishing attention given to medical marijuana ahead of her appearance at the Benzinga Cannabis Capital Conference in Chicago this October.

Medical Marijuana Pushed Aside

According to Borchardt, the current lack of attention toward medical marijuana may be tied to the absence of robust FDA-approved clinical trials. “Medical marijuana will likely stay in the …

Full story available on Benzinga.com